BioSpace News Archive

Status Regarding Novo Nordisk A/S’s Holding of Its Own Shares

October 1, 2012
·
1 min read
Drug Development

Medivation, Inc. and Astellas Pharma Inc. Announce New Data From XTANDI® (enzalutamide) Pivotal Study

October 1, 2012
·
9 min read
Pharm Country

Celsion Corporation Announces DIGNITY Study Data Presented at 2012 Congress for European Society of Medical Oncology

October 1, 2012
·
5 min read
GeoVax Labs Inc. Awarded $1.9 Million Grant by U.S. Government for HIV/AIDS Vaccine Program

October 1, 2012
·
3 min read
Drug Development

Cleveland Biolabs Inc. Receives FDA Meeting Minutes and Advice Letter on Clinical Protocol for Development of Entolimod (CBLB502) as Radiation Countermeasure

October 1, 2012
·
1 min read
Drug Development

Bavarian Nordic Reports Preliminary Data From Phase 2 Trial of CV-301 in Metastatic Breast Cancer

October 1, 2012
·
1 min read
Policy

Senomyx, Inc. Receives Generally Recognized as Safe (GRAS) Determinationa for New S9632 Flavor Ingredient

October 1, 2012
·
1 min read
Drug Development

CytRx Corporation’s Aldoxorubicin Clinical Data Presented at the ESMO 2012 Congress

October 1, 2012
·
1 min read
Pharm Country

Bristol-Myers Squibb Company Release: New Four- and Five-Year Survival Data for YERVOY® (ipilimumab) in Treatment-Naïve and Previously-Treated Metastatic Melanoma Presented at the ESMO 2012 Congress (European Society for Medical Oncology)

October 1, 2012
·
1 min read
Drug Development

BioAlliance Pharma: Presentation of Phase I Clinical Results With AMEP® Biotherapy in the Treatment of Metastatic Melanoma

October 1, 2012
·
1 min read